Trifarotene for Acne Vulgaris

   Rated 0 / 5 stars

Save

Listen to the episode

Description

In this episode:

Dr Ryan De Cruz, specialist dermatologist and head of Bone Marrow Transplant – Dermatology Clinic at The Royal Melbourne Hospital, explains the role of trifarotene for acne vulgaris how it is administered and when it should be used.

Expert: Dr Ryan De Cruz, Specialist Dermatologist; Fellow of the Australasian College of Dermatologists (FACD), Head of Bone Marrow Transplant, Dermatology Clinic, The Royal Melbourne Hospital, Founder, Southern Dermatology

Total time: 6 mins

Last Updated: 25 Oct, 2021

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Deb Mills

Dr Deb Mills

Travel Medicine Update for General Practice

Dr Katherine Spira

Dr Katherine Spira

Choosing the Right Migraine Preventative

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Expert Panel – Atherosclerosis and Blood Lipid Management

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism – When & Who to Refer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Ryan De Cruz

expert

Dr Ryan De Cruz

Specialist Dermatologist; Fellow of the Australasian College of Dermatologists (FACD), Head of Bone Marrow Transplant, Dermatology Clinic, The Royal Melbourne Hospital, Founder, Southern Dermatology

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.